Product Images Xarelto
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 13 images provide visual information about the product associated with Xarelto NDC 50090-3625 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Image - lbl500903625
The text appears to be a product description for XARELTO, including a product number (6831-0), tablet quantity (90), and possibly a price ($3625.0). It is unclear what "LoF" and "{Eavgononn Ay" refer to.*
Figure 1 - xarelto 01
This appears to be a table displaying different variables including hazard ratio, confidence interval, weight, age, prior stroke, diabetic status, and other variables. The table compares the likelihood of favoring Rivoxaban versus Warfarin in different populations.*
Figure 2 - xarelto 02
This appears to be a table with various medical variables and their corresponding values. The first column indicates the different variables considered, such as age, sex, weight, and medical history. The remaining columns show the percentage or number of cases in each category, but it is not clear what the context or purpose of the table is without further information.*
Chemical Structure - xarelto 03
Figure 3 - xarelto 04
The text describes the population description, fold change, and 90% CI of various groups including those with end-stage renal disease, renal impairment, age differences, bodyweight differences, and hepatic impairment. The post-dialysis and normal measurements were taken for patients with end-stage renal disease, and the findings here are from a single dose of rivaroxaban post hemodialysis. The text also includes the creatinine clearance values for the different levels of renal impairment. The findings are presented in terms of AUC, Cmax, and relative change to reference.*
Figure 4 - xarelto 05
The provided text shows a table that presents the fold change values and the 90% CI range for drug interaction PK in several drugs including inhibitors, inducers, and other groups. The drugs mentioned are Ketoconazole, Ritonavir, Clarithromycin, Erythromycin, Fluconazole, Rifampicin, Aspirin, Atorvastatin, Clopidogrel, Digoxin, Enoxaparin, Meloxicam, Midazolam, Naproxen, Omeprazole, and Ranitidine. The table also indicates the change relative to Rivaroxaban alone with time intervals of 0.25, 0.5, 1, 2, and 4.*
Figure 5 - xarelto 06
This appears to be a table with information about cumulative event rates (%), HR (95% CI), and the number of subjects at risk for XARELTO and Warfarin. The table also shows how many days have passed since randomization. There may be additional information in the full document, but this text alone is not providing enough context to determine exactly what the table is describing.*
Figure 6 - xarelto 07
Figure 7 - xarelto 08
Figure 8 - xarelto 09
Figure 9 - xarelto 10
Figure 10 - xarelto 11
Figure 11 - xarelto 12
This appears to be a graph showing the cumulative probability of a comparison between XARELTO + Aspirin and Aspirin. The comparison shows the Hazard Ratio (95% Confidence Interval). The graph is plotted against time in days from Randomization, with the number of subjects at risk indicated.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.